- Hannah Ritchie and Max Roser (2018) Mental Health. Published online at OurWorldInData.org. Available from: https://ourworldindata.org/mental-health [Accessed March 2022]
You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.
UK-NOTPR-1010 | April 2022
We are always available to take your enquiries.
For UK general enquiries please give us a call at +44 1908 649966 or you can email us at email@example.com.
Lundbeck is a global pharmaceutical company specialising in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
Millions of people worldwide are living with brain diseases.1 At Lundbeck, every day, we strive for improved treatment and a better life for people living with brain diseases.
We have approximately 5,600 employees in more than 50 countries who are engaged in the entire value chain throughout research, development, production, marketing and sales.
Our pipeline consists of several Research and Development programmes and our products are available in more than 100 countries. We have research centres in Denmark and the US and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 17.7 billion in 2020 (EUR 2.4 billion; USD 2.7 billion).
Connect with us on Twitter at @LundbeckUK and via our LundbeckUK LinkedIn page to learn more about the work we do in the UK and our focus on Brain Diseases.
In the forefront of neuroscience research
Countries of operation around the world
Of revenue generated in 2020
UK-NOTPR-0646 | April 2022